Biotech 

Creative Biogene Develops Lung Cancer Products to Support Oncology Diagnosis

      

(YorkPedia Editorial):- New York City, New York May 31, 2022 (Issuewire.com) – Creative Biogene, a leading provider of biotechnology products and services, focuses on the research and development of diagnostic products. The core diagnostic capabilities include flow cytometry, enzyme-linked immunoassay, chemiluminescence immunoassay, and molecular diagnosis. Creative Biogene is committed to providing customers with the best products to help quickly solve the problems in diagnostic research. Recently, Creative Biogene announced the release of its lung cancer products in order to support oncology diagnosis.

Molecular diagnosis of tumors refers to the molecular biological diagnosis technology with nucleic acid or protein as the core. By detecting biological macromolecules related to tumorigenesis, tumorigenesis can be predicted and diagnosed, and the effect of tumor treatment can be evaluated, which can provide a reference for tumor prognosis and prognosis. Genetic testing provided by Creative Biogene includes in situ hybridization, fluorescence in situ hybridization, in situ PCR, Southern hybridization, Northern hybridization, comparative genomic hybridization, etc. The available tumor marker detection methods of Creative Biogene include immunohistochemistry, enzyme-linked immunosorbent assay, Western blotting technology, flow cytometry, protein chip, tissue chip, radioimmunoassay, immunoelectron microscopy, apoptotic cell detection, and biological mass spectrometry, etc.

More on YorkPedia:

Creative Biogene’s lung cancer diagnostic products are mainly FISH probe kits. Currently, FISH is still the gold standard for lung cancer diagnosis. Due to its high sensitivity and specificity, simplicity, and speed, FISH technology allows direct visualization of evidence of DNA amplification at the cellular level (nuclei). Moreover, the number of amplified DNA fluorescent signals displayed on the nucleus is related to technical advantages such as the level of amplification and plays an irreplaceable role in clinical applications.

At present, the common proto-oncogene families include src family, ras family, myc family, sis family, and myb family. Common tumor suppressor genes include the Rb gene and P53 gene, all of which can be found in Creative Biogene’s corresponding products. Alternative tumor-associated viruses include DNA viruses and RNA viruses. Oncogenic DNA viruses include HPV, HBV, EBV, HHV-8, etc., and tumorigenic RNA viruses include HTLV-1, and HCV.

“Creative Biogene is committed to improving the health and well-being of people around the world by developing diagnostic solutions and providing customers with the best products to help them quickly solve problems in diagnostic research.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “we are capable to provide customized solutions in order to satisfy the specific requirement for individual programs.”

About Creative Biogene
Creative Biogene is dedicated to offering innovative technologies, products, unique tools, and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader in the field of drug development, biomedical, and genetics to support researchers worldwide.

(YorkPedia Editorial):- New York City, New York May 31, 2022 (Issuewire.com) – Creative Biogene, a leading provider of biotechnology products and services, focuses on the research and development of diagnostic products. The core diagnostic capabilities include flow cytometry, enzyme-linked immunoassay, chemiluminescence immunoassay, and molecular diagnosis. Creative Biogene is committed to providing customers with the best products to help quickly solve the problems in diagnostic research. Recently, Creative Biogene announced the release of its lung cancer products in order to support oncology diagnosis.

Molecular diagnosis of tumors refers to the molecular biological diagnosis technology with nucleic acid or protein as the core. By detecting biological macromolecules related to tumorigenesis, tumorigenesis can be predicted and diagnosed, and the effect of tumor treatment can be evaluated, which can provide a reference for tumor prognosis and prognosis. Genetic testing provided by Creative Biogene includes in situ hybridization, fluorescence in situ hybridization, in situ PCR, Southern hybridization, Northern hybridization, comparative genomic hybridization, etc. The available tumor marker detection methods of Creative Biogene include immunohistochemistry, enzyme-linked immunosorbent assay, Western blotting technology, flow cytometry, protein chip, tissue chip, radioimmunoassay, immunoelectron microscopy, apoptotic cell detection, and biological mass spectrometry, etc.

Creative Biogene’s lung cancer diagnostic products are mainly FISH probe kits. Currently, FISH is still the gold standard for lung cancer diagnosis. Due to its high sensitivity and specificity, simplicity, and speed, FISH technology allows direct visualization of evidence of DNA amplification at the cellular level (nuclei). Moreover, the number of amplified DNA fluorescent signals displayed on the nucleus is related to technical advantages such as the level of amplification and plays an irreplaceable role in clinical applications.

At present, the common proto-oncogene families include src family, ras family, myc family, sis family, and myb family. Common tumor suppressor genes include the Rb gene and P53 gene, all of which can be found in Creative Biogene’s corresponding products. Alternative tumor-associated viruses include DNA viruses and RNA viruses. Oncogenic DNA viruses include HPV, HBV, EBV, HHV-8, etc., and tumorigenic RNA viruses include HTLV-1, and HCV.

“Creative Biogene is committed to improving the health and well-being of people around the world by developing diagnostic solutions and providing customers with the best products to help them quickly solve problems in diagnostic research.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “we are capable to provide customized solutions in order to satisfy the specific requirement for individual programs.”

About Creative Biogene
Creative Biogene is dedicated to offering innovative technologies, products, unique tools, and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader in the field of drug development, biomedical, and genetics to support researchers worldwide.

Media Contact
Marcia Brady
[email protected]
6313868241
Shirley, NY 11967, USA
https://corelab.creative-biogene.com/

Creative Biogene
[email protected]
Shirley, NY 11967, USA

11967
1-631-386-8241
https://www.creative-biogene.com/

Source :Creative Biogene

This article was originally published by IssueWire. Read the original article here.


      

Related posts